OPS
ASND icon

Orion Portfolio Solutions’s Ascendis Pharma A/S ASND Stock Holding History

Orion Portfolio Solutions’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9
Closed -$1K – 541
2020
Q2 		$1K Hold
9
– – ﹤0.01% 1898
2020
Q1 		$1K Hold
9
– – ﹤0.01% 1676
2019
Q4 		$1K Buy
+9
New +$1K ﹤0.01% 1605

Other funds holding ASND

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Orion Portfolio Solutions's ASND Position: Q3 2020 in Review

Orion Portfolio Solutions sold out of Ascendis Pharma A/S (ASND) in Q3 2020, closing a stake of 9 shares — an estimated $1K sold.

Orion Portfolio Solutions first reported a position in ASND in Q4 2019 and held it in 3 quarters. The position peaked at $1K in Q2 2020. 152 funds tracked by Wall St. Rank hold ASND as of Q3 2020.

  • Orion Portfolio Solutions reported no remaining Ascendis Pharma A/S position as of Q3 2020 after selling out during the quarter.
  • Orion Portfolio Solutions sold 9 Ascendis Pharma A/S shares in Q3 2020, an estimated $1K.
  • Orion Portfolio Solutions first reported a position in Ascendis Pharma A/S in Q4 2019 and held it in 3 quarters.
  • Orion Portfolio Solutions's Ascendis Pharma A/S position peaked at $1K in Q2 2020.
  • 152 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2020.

Based on Orion Portfolio Solutions's 13F filing for Q3 2020, filed 13 Nov 2020.